$17.59
PepGen (PEPG) is a leading biotechnology business based in the US. It opened the day at $17.00 after a previous close of $16.99. During the day the price has varied from a low of $17.00 to a high of $17.90. The latest price was $17.59 (25 minute delay). PepGen is listed on the NASDAQ and employs 65 staff. All prices are listed in US Dollars.
Our top picks for where to buy PepGen stock
How to buy PepGen stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PEPG. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy PepGen stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
PepGen stock price (NASDAQ: PEPG)
Use our graph to track the performance of PEPG stocks over time.PepGen shares at a glance
Open | $17.00 |
---|---|
High | $17.90 |
Low | $17.00 |
Close | $17.59 |
Previous close | $16.99 |
Change | $0.60 |
Change % | 3.5315% |
Volume | 45,480 |
52-week range | $3.72 - $18.72 |
---|---|
50-day moving average | $16.25 |
200-day moving average | $11.29 |
Wall St. target price | $21.60 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-3.24 |
Is it a good time to buy PepGen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PepGen price performance over time
Historical closes compared with the close of $17.59 from 2024-07-23
1 week (2024-07-17) | -1.51% |
---|---|
1 month (2024-06-24) | -1.40% |
3 months (2024-04-24) | 48.69% |
6 months (2024-01-24) | 159.06% |
1 year (2023-07-24) | 132.06% |
---|---|
2 years (2022-07-22) | 49.19% |
3 years (2021-07-20) | N/A |
5 years (2019-07-20) | N/A |
PepGen financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -26.51% |
Return on equity TTM | -46.72% |
Profit margin | 0% |
Book value | $5.53 |
Market Capitalization | $536.5 million |
TTM: trailing 12 months
PepGen share dividends
We're not expecting PepGen to pay a dividend over the next 12 months.
PepGen share price volatility
Over the last 12 months, PepGen's shares have ranged in value from as little as $3.72 up to $18.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PepGen's is 1.73. This would suggest that PepGen's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
PepGen overview
PepGen Inc. , a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts. .
Frequently asked questions
What percentage of PepGen is owned by insiders or institutions?Currently 0.018% of PepGen shares are held by insiders and 91.017% by institutions. How many people work for PepGen?
Latest data suggests 65 work at PepGen. When does the fiscal year end for PepGen?
PepGen's fiscal year ends in December. Where is PepGen based?
PepGen's address is: 321 Harrison Avenue, Boston, MA, United States, 02118 What is PepGen's ISIN number?
PepGen's international securities identification number is: US7133171055
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question